title: Important role for Toll-like receptor 9 in host defense against meningococcal sepsis.
abstract: Neisseria meningitidis is a leading cause of meningitis and sepsis. The pathogenesis of meningococcal disease is determined by both bacterial virulence factors and the host inflammatory response. Toll-like receptors (TLRs) are prominent activators of the inflammatory response, and TLR2, -4, and -9 have been reported to be involved in the host response to N. meningitidis. While TLR4 has been suggested to play an important role in early containment of infection, the roles of TLR2 and TLR9 in meningococcal disease are not well described. Using a model for meningococcal sepsis, we report that TLR9(-/-) mice displayed reduced survival and elevated levels of bacteremia compared to wild-type mice. In contrast, TLR2(-/-) mice controlled the infection in a manner comparable to that of wild-type mice. TLR9 deficiency was also associated with reduced bactericidal activity in vitro, which was accompanied by reduced production of nitric oxide by TLR9-deficient macrophages. Interestingly, TLR9(-/-) mice recruited more macrophages to the bloodstream than wild-type mice and produced elevated levels of cytokines at late time points during infection. At the cellular level, activation of signal transduction and induction of cytokine gene expression were independent of TLR2 or TLR9 in macrophages and conventional dendritic cells. In contrast, plasmacytoid dendritic cells relied entirely on TLR9 to induce these activities. Thus, our data demonstrate an important role for TLR9 in host defense against N. meningitidis.
authors.affiliation: Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, P.O. Box 582, Uppsala, Sweden. hong.sjolinder@imbim.uu.se
authors.forename: Hong
authors.initials: H
authors.lastname: Sjölinder
authors.forename: Trine H
authors.initials: TH
authors.lastname: Mogensen
authors.forename: Mogens
authors.initials: M
authors.lastname: Kilian
authors.forename: Ann-Beth
authors.initials: AB
authors.lastname: Jonsson
authors.forename: Søren R
authors.initials: SR
authors.lastname: Paludan
mesh_terms: D000818:Animals; D016470:Bacteremia / Q000276:immunology* / Q000378:metabolism; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism; D005260:Female; D015870:Gene Expression / Q000276:immunology; D008264:Macrophages / Q000276:immunology / Q000378:metabolism; D008589:Meningococcal Infections / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D009345:Neisseria meningitidis / Q000276:immunology* / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis; D015398:Signal Transduction / Q000276:immunology*; D051195:Toll-Like Receptor 2 / Q000276:immunology; D051217:Toll-Like Receptor 9 / Q000276:immunology* / Q000378:metabolism
chemical_list: D016207:Cytokines; C493486:Tlr2 protein, mouse; C495370:Tlr9 protein, mouse; D051195:Toll-Like Receptor 2; D051217:Toll-Like Receptor 9; D009569:Nitric Oxide
references.citation: Cell Microbiol. 2007 Mar;9(3):657-69
references.pmid: 17026481
references.citation: J Exp Med. 2008 Jun 9;205(6):1277-83
references.pmid: 18474631
references.citation: Infect Immun. 1979 May;24(2):545-51
references.pmid: 110703
references.citation: J Exp Med. 2007 May 14;204(5):987-94
references.pmid: 17452523
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6075-80
references.pmid: 12730365
references.citation: Science. 1979 Jul 20;205(4403):298-9
references.pmid: 451601
references.citation: Infect Immun. 2004 Jan;72(1):371-80
references.pmid: 14688118
references.citation: Infect Immun. 2005 Oct;73(10):6838-45
references.pmid: 16177362
references.citation: Nat Rev Immunol. 2004 Jul;4(7):499-511
references.pmid: 15229469
references.citation: Pediatr Infect Dis J. 2006 Jan;25(1):80-1
references.pmid: 16395111
references.citation: J Clin Invest. 2005 Mar;115(3):695-702
references.pmid: 15765149
references.citation: J Immunol. 2007 Sep 15;179(6):3937-46
references.pmid: 17785831
references.citation: Infect Immun. 2008 Jan;76(1):189-97
references.pmid: 17938219
references.citation: Lancet Infect Dis. 2003 Sep;3(9):565-77
references.pmid: 12954563
references.citation: Nature. 2000 Dec 7;408(6813):740-5
references.pmid: 11130078
references.citation: Scand J Immunol. 2006 Dec;64(6):646-54
references.pmid: 17083621
references.citation: J Immunol. 2002 Feb 15;168(4):1533-7
references.pmid: 11823477
references.citation: J Immunol. 2004 Dec 1;173(11):6890-8
references.pmid: 15557184
references.citation: J Immunol. 2008 Feb 15;180(4):2474-85
references.pmid: 18250457
references.citation: J Leukoc Biol. 2006 Aug;80(2):267-77
references.pmid: 16731773
references.citation: N Engl J Med. 2001 May 3;344(18):1378-88
references.pmid: 11333996
references.citation: Eur J Immunol. 2007 Oct;37(10):2847-55
references.pmid: 17853411
references.citation: PLoS One. 2007 Feb 21;2(2):e241
references.pmid: 17311106
references.citation: Infect Immun. 1998 Jan;66(1):213-7
references.pmid: 9423860
references.citation: Infect Immun. 2006 Dec;74(12):6982-91
references.pmid: 17030578
references.citation: Infect Immun. 2006 Jun;74(6):3538-46
references.pmid: 16714586
references.citation: Cell. 2006 Feb 24;124(4):783-801
references.pmid: 16497588
references.citation: Respir Res. 2004 Nov 11;5:21
references.pmid: 15538945
references.citation: Cell Microbiol. 2007 Mar;9(3):633-44
references.pmid: 17004992
references.citation: J Exp Med. 2005 Dec 19;202(12):1715-24
references.pmid: 16365150
references.citation: J Virol. 2007 Dec;81(24):13315-24
references.pmid: 17913820
references.citation: Infect Immun. 2007 Jan;75(1):146-51
references.pmid: 17060467
references.citation: J Immunol. 2005 Apr 1;174(7):4295-300
references.pmid: 15778393
references.citation: FEMS Immunol Med Microbiol. 1999 Sep;25(4):385-9
references.pmid: 10497870
references.citation: J Immunol. 2006 Sep 15;177(6):3515-9
references.pmid: 16951309